Sylvia M. Wilson

3.3k citations

44 papers · 2.7k indexed · h-index 27

Rheumatology top 1%
- Bone and Dental Protein Studies 13
Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
Biotechnology top 1%
- Cancer Research and Treatments 6
Oncology top 2%
- Cancer Cells and Metastasis 4
- Bone health and treatments 4
Oral Surgery top 2%
- Oral and Maxillofacial Pathology 7
Genetics
- Virus-based gene therapy research 4
Molecular Biology
- dental development and anomalies 4

Co-authors: Ann F. Chambers Alan B. Tuck Ian C. MacDonald A. C. Groom George N. Naumov Frances P. O’Malley Vincent L. Morris Charulata Hota
Cited by: Rheumatology Cancer Research Biotechnology
Journals: The Lancet (1 paper)Journal of Biological Chemistry (1 paper)The Journal of Immunology (1 paper)
Partner nations: Canada United States United Kingdom

In The Last Decade

Sylvia M. Wilson

44 papers receiving 2.7k citations

Peers

Countries citing papers authored by Sylvia M. Wilson

Since Specialization

Citations

This map shows the geographic impact of Sylvia M. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia M. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia M. Wilson more than expected).

Fields of papers citing papers by Sylvia M. Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia M. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia M. Wilson. The network helps show where Sylvia M. Wilson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sylvia M. Wilson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvia M. Wilson Line = papers co-authored together Sylvia M. Wilson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease Molecular Pharmacology ·Thunicia Moodley,Sylvia M. Wilson,Taruna Joshi,Christopher F. Rider,Pawan Sharma,Yan Dong,Robert Newton,Mark A. Giembycz	2013	38
2	Evidence for a Second Receptor for Prostacyclin on Human Airway Epithelial Cells That Mediates Inhibition of CXCL9 and CXCL10 Release Molecular Pharmacology ·Sylvia M. Wilson,Neil A. Sheddan,Robert Newton,Mark A. Giembycz	2010	15
3	Effect of β₂-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A American Journal of Physiology-Lung Cellular and Molecular Physiology ·Manminder Kaur,Neil S. Holden,Sylvia M. Wilson,Maria B. Sukkar,Kian Fan Chung,Peter J. Barnes,Robert Newton,Mark A. Giembycz	2008	55
4	Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer Breast Cancer Research and Treatment ·Vivien Bramwell,Gordon S. Doig,Alan B. Tuck,Sylvia M. Wilson,Katia Tonkin,Anna Tomiak,Francisco Perera,Theodore A. Vandenberg,Ann F. Chambers	2008	41
5	4,5-Dihydro-1 H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) Is a Selective, Pseudo-Irreversible Orthosteric Antagonist at the Prostacyclin (IP)-Receptor Expressed by Human Airway Epithelial Cells: IP-Receptor-Mediated Inhibition of CXCL9 and CXCL10 Release Journal of Pharmacology and Experimental Therapeutics ·Linda M. Ayer,Sylvia M. Wilson,Suzanne Traves,David Proud,Mark A. Giembycz	2007	14
6	SnoN Is a Cell Type-specific Mediator of Transforming Growth Factor-β Responses Journal of Biological Chemistry ·Krishna Pada Sarker,Sylvia M. Wilson,Shirin Bonni	2005	60
7	Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways Oncogene ·Alan B. Tuck,Charulata Hota,Sylvia M. Wilson,Ann F. Chambers	2003	115
8	Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin. PubMed ·Kara A. Furger,Alison L. Allan,Sylvia M. Wilson,Charulata Hota,Sharon A. Vantyghem,Carl O. Postenka,Waleed Al‐Katib,Ann F. Chambers,Alan B. Tuck	2003	79
9	Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases Breast Cancer Research and Treatment ·George N. Naumov,Jason L. Townson,Ian C. MacDonald,Sylvia M. Wilson,Vivien Bramwell,A. C. Groom,Ann F. Chambers	2003	246
10	Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. PubMed ·Hemanth J. Varghese,Melanie Davidson,Ian C. MacDonald,Sylvia M. Wilson,Kishore V. Nadkarni,A. C. Groom,Ann F. Chambers	2002	50
11	Plasma osteopontin Cancer ·Sébastien J. Hotte,Eric Winquist,Larry Stitt,Sylvia M. Wilson,Ann F. Chambers	2002	137
12	Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells Oncogene ·Alan B. Tuck,Denise Arsenault,Frances P. O’Malley,Charulata Hota,Michael C. Ling,Sylvia M. Wilson,Ann F. Chambers	1999	172
13	Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases The Lancet ·Zahida Saad,Vivien Bramwell,Sylvia M. Wilson,Frances P. O’Malley,J Jeacock,Ann F. Chambers	1998	27
14	ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancer International Journal of Cancer ·Alan G. Casson,Sylvia M. Wilson,J. Andrea McCart,Frances P. O’Malley,Hilmi Özçelik,Ming‐Sound Tsao,Ann F. Chambers	1997	67
15	Osteopontin expression in lung cancer Lung Cancer ·Ann F. Chambers,Sylvia M. Wilson,Nancy Kerkvliet,Frances P. O’Malley,John F. Harris,Alan G. Casson	1996	175
16	Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo Clinical & Experimental Metastasis ·Rama Khokha,Mitchell J. Zimmer,Sylvia M. Wilson,Ann F. Chambers	1992	64
17	Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression Journal of Neuro-Oncology ·Ann F. Chambers,Georgetta Denhardt,Sylvia M. Wilson,J. Gregory Cairncross	1991	2
18	Gene expression and metastasis of somatic cell hybrids between murine fibroblast cell lines of different malignant potential Somatic Cell and Molecular Genetics ·Alan B. Tuck,Sylvia M. Wilson,Fred R. Sergovich,Ann F. Chambers	1991	4
19	ras Transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cells Clinical & Experimental Metastasis ·Alan B. Tuck,Sylvia M. Wilson,Ann F. Chambers	1990	18
20	Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo Clinical & Experimental Metastasis ·Ann F. Chambers,Sylvia M. Wilson	1988	26

About Sylvia M. Wilson

Sylvia M. Wilson is a scholar working on Oral Surgery, Rheumatology and Oncology, having authored 44 papers that have together received 2.7k indexed citations. Recurring topics across this work include Bone and Dental Protein Studies (13 papers), Oral and Maxillofacial Pathology (7 papers), Cancer Research and Treatments (6 papers), Virus-based gene therapy research (4 papers), Cancer Cells and Metastasis (4 papers), Protease and Inhibitor Mechanisms (4 papers), Bone health and treatments (4 papers) and dental development and anomalies (4 papers). The work is most often cited by research in Rheumatology (851 citations), Cancer Research (643 citations) and Biotechnology (354 citations). Sylvia M. Wilson has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ann F. Chambers, Alan B. Tuck, Ian C. MacDonald, A. C. Groom, George N. Naumov, Frances P. O’Malley, Vincent L. Morris, Charulata Hota, Vivien Bramwell and Nancy Kerkvliet. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact